Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care : Voting results

share with twitter share with LinkedIn share with facebook
08/27/2020 | 11:47am EDT

Fresenius Medical Care AG & Co. KGaA, Bad Homburg

Annual General Meeting, 27.08.2020

Voting results - Overview

Voting presence

239.542.177 votes

78,68 % of registered capital

Shares for which valid votes

Yes votes

No votes

Abstention

were cast

Agenda

Number

% of

Number

%

Number

%

Number

registered

capital

Item 1

Resolution on the approval of the annual financial statements of Fresenius

239.149.699

78,55 %

239.042.035

99,95 %

107.664

0,05 %

391.983

Medical Care AG & Co. KGaA for fiscal year 2019

Item 2

Resolution on the allocation of distributable profit

239.350.833

78,62 %

239.078.344

99,89 %

272.489

0,11 %

190.734

Item 3

Resolution on the approval of the actions of the General Partner for fiscal year

144.486.081

47,46 %

139.568.796

96,60 %

4.917.285

3,40 %

675.324

2019

Item 4

Resolution on the approval of the actions of the Supervisory Board for fiscal year

136.884.130

44,96 %

129.471.276

94,58 %

7.412.854

5,42 %

8.277.220

2019

Item 5

Election of the auditor and consolidated group auditor for fiscal year 2020 as well

144.975.704

47,62 %

143.262.437

98,82 %

1.713.267

1,18 %

185.616

as the auditor for the potential review of interim financial information

Item 6

Resolution on the approval of the compensation system for the members of the

236.148.079

77,57 %

224.456.536

95,05 %

11.691.543

4,95 %

3.393.708

Management Board of the General Partner

Item 7

Resolution on the remuneration of the members of the Supervisory Board and on

238.512.845

78,35 %

234.976.150

98,52 %

3.536.695

1,48 %

1.028.942

the amendment of Article 13 and Article 13e (3) of the Articles of Association

Item 8

Resolution on the cancellation of the existing authorized capitals, on the creation

239.299.674

78,60 %

225.141.013

94,08 %

14.158.661

5,92 %

242.113

of new authorized capitals incl. the possibility of the exclusion of subscription

rights and on corresponding amendments to Art. 4 (3) and (4) of the Articles

Item 9

Resolution on the amendment of Article 15 (1) sentence 2 of the Company's

239.297.436

78,60 %

239.268.905

99,99 %

28.531

0,01 %

244.351

Articles of Association (Alignment with the German Stock Corporation Act as

amended by the ARUG II)

Disclaimer

FMC - Fresenius Medical Care AG & Co. KGaA published this content on 27 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 August 2020 14:47:17 UTC


share with twitter share with LinkedIn share with facebook
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
10/23FRESENIUS SE : Receives a Buy rating from Goldman Sachs
MD
10/23FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Goldman Sachs
MD
10/22FRESENIUS SE : Credit Suisse reiterates its Neutral rating
MD
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reaffirms its Neutral ratin..
MD
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse remains Neutral
MD
10/21FRESENIUS SE : Berenberg reiterates its Buy rating
MD
10/21Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva t..
AQ
10/21FRESENIUS SE : Barclays reiterates its Buy rating
MD
10/21FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from Barclays
MD
10/20FRESENIUS MEDICAL CARE : gets FDA approval for Biofine® PD solution bags
PU
More news
Financials (USD)
Sales 2020 21 508 M - -
Net income 2020 1 548 M - -
Net Debt 2020 14 308 M - -
P/E ratio 2020 15,4x
Yield 2020 1,74%
Capitalization 23 836 M 23 792 M -
EV / Sales 2020 1,77x
EV / Sales 2021 1,66x
Nbr of Employees 124 736
Free-Float 65,1%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 99,78 $
Last Close Price 81,40 $
Spread / Highest target 41,0%
Spread / Average Target 22,6%
Spread / Lowest Target -1,84%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer